Figure 1:(A) Uvéite antérieure et sclérite diffuse induites par l'administration de pamidronate
chez une femme de 58 ans. Exophtalmie, hypopion (flèche bleue), et injection et un œdème …

A 58-year-old, bisphosphonate-naive woman with a history of Hashimoto thyroiditis was
admitted to hospital for hypercalcemia (2.81 [normal 2.20–2.60] mmol/L) due to primary …

S ir, A 71‐yr‐old gentleman was referred with known Paget's disease. He had presented
previously with chronic intermittent back and left thigh pain. He had been partially deaf for 8 …

Pamidronate and Uveltis SIR—We wish to report the case of a patient with polyostotic
Paget's disease of bone who developed severe acute anterior uveitis 24 h after completing …

Ophthalmologic adverse effects of bisphosphonate therapy are infrequent and of unclear
pathogenesis. The most common has been anterior uveitis, of which 18 cases have been …

Background Zoledronic acid-induced uveitis (ZAIU) is rare but severe, and has been
recently considered part of an acute phase reaction. Only 15 cases have been reported …

[Acute anterior uveitis associated with the use zoledronic acid]. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Ocular adverse effects of pamidronic acid are rare but well documented. Pamidronate, an
inhibitor of bone resorption used primarily in the management of tumor-induced …

Zoledronic acid (Aclasta, Novartis Pharmaceuticals, Canada) is a bisphosphonate used in
the treatment of osteoporosis, Paget's disease of the bone, and hypercalcemia associated …

Bisphosphonates are widely used to treat several clinical conditions. Zoledronic acid is one
of this class, commonly used for the treatment and prevention of osteoporosis …